Showing results (391-400 of 541) with videos related to

Sort By:
Pageof 55
Drugs - Real World Outcomes|July 23, 2026
Calcitonin Gene-Related Peptide Monoclonal Antibody Utilization and Treatment Gaps in People with Migraine in Japan: Results from the OVERCOME (Japan) 2nd StudyYoshiki Hanaoka, Tsubasa Takizawa, Ryotaro Ishii, et al.
Drugs - Real World Outcomes|July 29, 2026
Residual Burden in Adalimumab-Treated Patients with Hidradenitis Suppurativa: An Observational Cohort Study Based on Insurance Claims in the USAMaria A Aleshin, Tanja Tran, Ingrid Pansar, et al.
Drugs - Real World Outcomes|July 23, 2026
Feasibility of Reconstructing Survival Outcomes from Unstructured Electronic Medical Records under Japan's Next-Generation Medical Infrastructure Act: A Historical Cohort Study of Atezolizumab in Non-small Cell Lung CancerMasahiko Nakatsui, Yosuke Nishida, Suguru Nozue, et al.
Drugs - Real World Outcomes|December 23, 2015
Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical AntipsychoticsJacqueline A Pesa, Erik Muser, Leslie B Montejano, et al.
Drugs - Real World Outcomes|December 23, 2015
How Drug Use by French Elderly Patients Has Changed During the Last DecadeJean-François Huon, Emilie Lenain, Julien LeGuen, et al.
Drugs - Real World Outcomes|December 22, 2015
European Survey of Prescriber Understanding of Risks Associated with RetigabineLianna Ishihara, Anne Lewis, Sathish Kolli, et al.
Drugs - Real World Outcomes|December 22, 2015
Efficacy of Low-Dose Oral Liquid Morphine for Elderly Patients with Chronic Non-Cancer Pain: Retrospective Chart ReviewJoyce Lee, S Fatima Lakha, Angela Mailis
Drugs - Real World Outcomes|January 31, 2025
Trends in Reports of Statin-Associated Immune-Mediated Necrotizing Myopathy Using the Japanese Adverse Drug Event Report DatabaseAkina Takami, Gen Terashima, Takumi Tajima, et al.
Drugs - Real World Outcomes|January 28, 2025
Characteristics of Patients with Hereditary Angioedema Who Reduced Lanadelumab Treatment Administration Frequency: A Retrospective Observational Study of US Claims DataNicole Princic, Kristin A Evans, Chintal H Shah, et al.
Drugs - Real World Outcomes|January 20, 2025
Comparative Efficacy of Lenvatinib Plus Immunotherapy and Regorafenib Plus Immunotherapy After Lenvatinib Failure for Advanced Hepatocellular Carcinoma: A Retrospective StudyZeyu Yu, Bin Leng, Ran You, et al.
Pageof 55